We are live on ! Find out more
TVTX icon

Travere Therapeutics
TVTX

65 hedge funds and large institutions have $265M invested in Travere Therapeutics in 2014 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

7,292% more call options, than puts

Call options by funds: $3.55M | Put options by funds: $48K

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

88% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 16

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

61% more capital invested

Capital invested by funds: $165M → $265M (+$101M)

8% more funds holding

Funds holding: 60 → 65 (+5)

Holders
65
Holders Change
+5
Holders Change %
+8.33%
% of All Funds
1.73%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
13
Increased
30
Reduced
16
Closed
7
Calls
$3.55M
Puts
$48K
Net Calls
+$3.5M
Net Calls Change
+$2.79M

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$10.5M
2
LOAMU
Lombard Odier Asset Management (USA)
New York
+$8.8M
3
PA
Perceptive Advisors
New York
+$5.81M
4
BFA
BlackRock Fund Advisors
California
+$4.09M
5
SAM
Senzar Asset Management
New York
+$3.55M

Top Sellers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
-$10.9M
2
AC
Ascend Capital
California
-$2.62M
3
TI
Turner Investments
Pennsylvania
-$1.16M
4
PI
Putnam Investments
Massachusetts
-$917K
5
OM
Opaleye Management
Massachusetts
-$828K
Name Holding Trade Value Shares
Change 		Change in
Stake
WSA
26
Wall Street Associates
California
$1.05M +$885K +85,500 New
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$859K +$726K +70,141 New
BCM
28
Bridgeway Capital Management
Texas
$831K +$200K +19,350 +40%
BIM
29
BlackRock Investment Management
Delaware
$743K -$704 -68 -0.1%
Charles Schwab
30
Charles Schwab
California
$642K +$75.3K +7,281 +16%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$558K +$250K +24,200 +113%
AQR Capital Management
32
AQR Capital Management
Connecticut
$497K +$21.7K +2,100 +5%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$481K +$1.74K +168 +0.4%
CSS
34
Cubist Systematic Strategies
Connecticut
$450K +$380K +36,762 New
AC
35
Armistice Capital
New York
$427K +$361K +34,874 New
AC
36
Ascend Capital
California
$391K -$2.62M -253,150 -89%
CS
37
Credit Suisse
Switzerland
$381K +$42K +4,061 +15%
TA
38
Teachers Advisors
New York
$350K – – –
Morgan Stanley
39
Morgan Stanley
New York
$287K +$231K +22,299 +1,864%
Citadel Advisors
40
Citadel Advisors
Florida
$274K +$211K +20,348 +980%
ProShare Advisors
41
ProShare Advisors
Maryland
$272K +$230K +22,252 New
MLICM
42
Metropolitan Life Insurance Company (MetLife)
New York
$247K – – –
Dimensional Fund Advisors
43
Dimensional Fund Advisors
Texas
$244K +$207K +19,961 New
TI
44
Telemetry Investments
New York
$226K +$191K +18,500 New
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$216K +$5.43K +525 +3%
JAM
46
JW Asset Management
Florida
$202K +$170K +16,459 New
NFA
47
Nationwide Fund Advisors
Ohio
$195K -$5.09K -492 -3%
VOYA Investment Management
48
VOYA Investment Management
Georgia
$187K – – –
TI
49
Trexquant Investment
Connecticut
$179K +$152K +14,670 New
AIG
50
American International Group
New York
$164K -$5.47K -529 -4%
1
2
3

TVTX Hedge Fund Activity: Q4 2014 in Review

65 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Travere Therapeutics (TVTX) for Q4 2014, worth a combined $265M — up 61% from $165M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new TVTX positions and 7 closed out — a net gain of 6 holders — while 30 added to existing stakes and 16 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $10.5M. The largest seller was QVT Financial, cutting an estimated $10.9M.

  • 65 institutional investors held Travere Therapeutics (TVTX) as of Q4 2014, up from 60 in Q3 2014.
  • Funds reported $265M of Travere Therapeutics stock for Q4 2014, up 61% quarter-over-quarter.
  • 13 funds opened new Travere Therapeutics positions in Q4 2014 and 7 closed out, a net change of +6 holders.
  • The largest Travere Therapeutics buyer in Q4 2014 was Consonance Capital Management, an estimated $10.5M added.
  • The largest Travere Therapeutics seller in Q4 2014 was QVT Financial, an estimated $10.9M sold.

Based on aggregated 13F filings for Q4 2014.